125 related articles for article (PubMed ID: 2952933)
1. Neck node immunoreactivity in head and neck carcinoma.
Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
3. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
[TBL] [Abstract][Full Text] [Related]
4. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
5. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
[TBL] [Abstract][Full Text] [Related]
6. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
[TBL] [Abstract][Full Text] [Related]
7. Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma.
Kessler DJ; Mickel RA; Lichtenstein A
Arch Otolaryngol Head Neck Surg; 1988 Mar; 114(3):313-8. PubMed ID: 3342125
[TBL] [Abstract][Full Text] [Related]
8. Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck.
Roubin R; Bekkoucha F; Fondaneche MC; Quan PC; Micheau C; Cachin Y; Burtin P
J Cancer Res Clin Oncol; 1982; 102(3):277-87. PubMed ID: 6977544
[TBL] [Abstract][Full Text] [Related]
9. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
10. Impact of metastases on nodal immunoreactivity in head and neck cancer.
Schuller DE; Koolemans-Beynen AR; Libby DH; Rinehart JJ; Milo GE
Laryngoscope; 1986 Nov; 96(11):1189-92. PubMed ID: 3773614
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 of the upper aerodigestive tract.
Johnson JT; Rabin BS; Wagner RL
Ann Otol Rhinol Laryngol; 1987; 96(2 Pt 1):213-6. PubMed ID: 3471170
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell response to regional lymph node metastases.
Schantz SP; Poisson L
Arch Otolaryngol Head Neck Surg; 1986 May; 112(5):545-51. PubMed ID: 3954896
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma.
Kumagai K; Hamada Y; Gotoh A; Kobayashi H; Kawaguchi K; Horie A; Yamada H; Suzuki S; Suzuki R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):341-50. PubMed ID: 20598595
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
Wang MB; Lichtenstein A; Mickel RA
Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
20. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]